<http://schema.org/description>
"Gilead Sciences is widely known for its HIV drug portfolio and for its high-profile hep-C drug sofosbuvir. But it also has a potential winner with idelalisib, a blood cancer drug with a promising future."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/10/15/you-shouldnt-ignore-gileads-idelalisib.aspx>